Jasper Therapeutics Inc. (NASDAQ:JSPR) jumped 17.4% in premarket trading Tuesday after the company released promising initial ...

In the 12 months after starting tezepelumab, patients with severe asthma had a lower annualized exacerbation rate, as well as lower exacerbation-related health care resource use and costs, according ...

A new injection, tezepelumab, could help severe asthma patients to stop oral steroids safely. It could reduce steroid-related ...

The charity is calling on the government to produce a national strategy for respiratory illness to avoid hospitals being ...

A new study from the UK suggests adults with anxiety or depression may face a higher risk of asthma attacks. Researchers ...

Please provide your email address to receive an email when new articles are posted on . “Asthma care in the Netherlands is divided between different health care providers, including respiratory ...

Background: Primary care physicians, who manage the care of most children with asthma, often do not optimally assess disease control, prescribe asthma controller medications, or provide family asthma ...

A medical manufacturer based in Maidstone, Kent, has had its breath analysis device for people with asthma registered in India, unlocking a new market for the company.

This story originally appeared on Next City. “Every time she came in with one of her children, it was never a wellness visit,” Christian Banchs says solemnly. Banchs, a nurse, is describing one of his ...

Asthma costs the UK health service at least £1.1 billion each year, researchers have estimated. The findings are the result of the most comprehensive study of the state of asthma in UK to date.